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Documento CUCS # 5C
C&SC200813(6)Costa-Cuoto (B)
Costa-Couto MH, Nascimento AC. Assimetria nas relaçoes internacionais,
propiedade industrial e medicamentos anti-aids. [Aysemmetry in
Internacional Relations, Industrial Property and Antiretroviral Medication
for HIV/AIDS]. Ciencia & Saúde Coletiva (Rio de Janeiro, Brasil) 2008
Noviembre-Diciembre; 13(6): 1869-1877.
Objectives: To analyze the asymmetry of international relations between the
U.S. and Brazil with respect to the recognition of industrial property and
technological innovations in the pharmaceutical industry.
Methodology: Descriptive analytical.
Results: For the authors, perceived international asymmetry is related to
conflicts of interest between United States and Brazil. While the Brazilian health
care system allows the free distribution of imported antiretrovirals, in the U.S., the
free distribution of medicines is much more limited and focused on a limited
number of diseases. In this sense, the authors notice that the network of services
in Brazil is based on the notion of universal right to health. It includes licenses to
promote access to medications, a cheaper supply of medicines through
production incentives, repeal of patent protection laws, and the institutionalization
of the use of generic drugs. The Sexually Transmitted Diseases Program in
Brazil, for example, proposes a combination of different drugs into a single drug
in order to reduce costs, increase treatment adherence and the quality of life for
patients. License development is regulated by governmental institutions and
national and international organizations. There are also agreements which
establish that public health should take precedence over commercial interests,
which broadens access to medicines for millions of patients with chronic
degenerative diseases. The United States, on the other hand, like other countries
with a neoliberal regime, allows the free distribution of medicines for only a small
number of diseases. Moreover, the United States requires the protection of
intellectual property of their patents in bilateral trade agreements with individual
countries, further limiting the distribution of medicines to the public. The Brazilian
experience in this field is favored by social mobilization, legislation, public
finance, decentralization of the health system, centralized resource management,
and prevention and treatment of HIV/AIDS to ensure access to antiretroviral
drugs.
Conclusions: For authors, the asymmetry of international relations concerning
medicine distribution and public health are solved with the construction of
agreements and pacts drawn from these considerations. They suggest firm,
purposeful action by the countries of the United Nations to strengthen
international relations and safeguard the collective interest above individual
interests and transnational corporations.

